Literature DB >> 24231290

Avian influenza A (H5N1) virus antibodies in pigs and residents of swine farms, southern China.

Nan Cao1, Wanjun Zhu, Ye Chen, Likai Tan, Pei Zhou, Zhenpeng Cao, Changwen Ke, Yugu Li, Jie Wu, Wenbao Qi, Peirong Jiao, Guihong Zhang.   

Abstract

BACKGROUND: Since 1997, the H5 avian influenza viruses (AIVs) circulating in China have become an international concern. Clade 2.3.2 of H5N1 AIVs is genetically distinct from the viruses isolated before 2007 and antigenically different from the vaccine strains widely used in China. Swine farms in rural China are thought to play an important role in AIVs ecology.
OBJECTIVES: A seroepidemiological study was undertaken among swine farm residents and pigs to understand the prevalence of antibodies against H5N1 AIVs in southern China. STUDY
DESIGN: During the period March 24, 2008 to December 25, 2012,serum samples were collected from 1606 swine farm residents on 40 swine farms in southern China. A total of 1980 pigs' serum samples were collected in the same swine farms where swine workers' serum samples were collected from March 2009 to March 2013. For a control group, 104 serum samples were collected from healthy city residents in Nanchang. All the serum samples were collected to perform hemagglutination inhibition (HI) and (neutralization) NT assays to investigate the prevalence of H5N1 AIV infections in southern China.
RESULTS: Sixteen human samples were positive by HI assay and 10 of these were also positive by NT assay against H5N1. No serum samples from human control and pigs were HI positive for H5N1 AIV. DISCUSSION: Our results demonstrate minimal transmission H5N1 AIV from birds to pigs in the swine farms studied and the risk of poultry-to-human and poultry-to-pig transmission for at least clades 2.3.2 seemed very low. This study provides the first data regarding antibodies against H5N1 AIV in humans and pigs on swine farms in China. The findings of this study can serve as a baseline for additional serologic studies to assess transmission of H5N1 viruses between avian species, pigs and swine workers.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  H5N1; Pigs; Swine farm residents

Mesh:

Substances:

Year:  2013        PMID: 24231290     DOI: 10.1016/j.jcv.2013.09.017

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

Review 1.  Swine influenza virus: Current status and challenge.

Authors:  Wenjun Ma
Journal:  Virus Res       Date:  2020-08-13       Impact factor: 3.303

2.  Serological Evidence and Risk Factors for Swine Influenza Infections among Chinese Swine Workers in Guangdong Province.

Authors:  Mengmeng Ma; Benjamin D Anderson; Tao Wang; Yingan Chen; Dingmei Zhang; Gregory C Gray; Jiahai Lu
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

3.  Evidence of exposure of domestic pigs to Highly Pathogenic Avian Influenza H5N1 in Nigeria.

Authors:  Clement Meseko; Anja Globig; Jeremiah Ijomanta; Tony Joannis; Chika Nwosuh; David Shamaki; Timm Harder; Donata Hoffman; Anne Pohlmann; Martin Beer; Thomas Mettenleiter; Elke Starick
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

Review 4.  A Systematic Review Analyzing the Prevalence and Circulation of Influenza Viruses in Swine Population Worldwide.

Authors:  Ravendra P Chauhan; Michelle L Gordon
Journal:  Pathogens       Date:  2020-05-08

5.  Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis.

Authors:  Xinhua Chen; Wei Wang; Yan Wang; Shengjie Lai; Juan Yang; Benjamin J Cowling; Peter W Horby; Timothy M Uyeki; Hongjie Yu
Journal:  BMC Med       Date:  2020-12-02       Impact factor: 8.775

6.  Pig trade networks through live pig markets in Guangdong Province, China.

Authors:  Yin Li; Baoxu Huang; Chaojian Shen; Chang Cai; Youming Wang; John Edwards; Guihong Zhang; Ian D Robertson
Journal:  Transbound Emerg Dis       Date:  2020-01-13       Impact factor: 4.521

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.